NEJM Evidence Issues Research Articles in March 2024 Edition
March 28, 2024
March 28, 2024
WALTHAM, Massachusetts, March 28 -- NEJM Evidence, a peer-reviewed journal from New England Journal of Medicine Group that says it presents clinical trial design and decision-making, published research articles on the following topics in its March 2024 edition:
Original Articles:
* Population-Based Disease Odds for E-Cigarettes and Dual Use versus Cigarettes
* Smoking Cessation and Short- and Longer-Term Mortality
* Mpox Neutralizing Antibody . . .
Original Articles:
* Population-Based Disease Odds for E-Cigarettes and Dual Use versus Cigarettes
* Smoking Cessation and Short- and Longer-Term Mortality
* Mpox Neutralizing Antibody . . .